| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |